Delivery Order SPE2DB22D3501-SPE2DB24FVB67
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $5,228.20 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the procurement of PROLIA 60 MG/ML syringe, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROLIA 60 MG/ML SYRINGEML. The contract has a ceiling value of $2,615.13 and a performance period through March 21, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc. doing business as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,743.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Prolia 60 mg/mL syringes. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564158415 PROLIA 60 MG/ML SYRINGEML. The contract has a ceiling value of $18,599.40 and a performance period through April 4, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to $999,999,999.00...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROLIA 60 MG/ML SYRINGE. The contract has a firm fixed price of $1,253.97 and a period of performance extending through June 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $6,428.70 and a completion date of June 10, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of July 2, 2025 and a ceiling value of $22,182.71. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The contract provides for the delivery of PROLIA 60 MG/ML SYRINGE to support military treatment programs and facilities. The contract has a potential value of $10,460.52 and a completion date of February 27, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, a for-profit organization and...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROLIA 60 MG/ML SYRINGE, a pharmaceutical product, with a ceiling value of $28,211.16 and a period of performance ending on July 1, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVB67Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract (SPE2DB22D3501|SPE2DB24FVB67) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide PROLIA 60 MG/ML SYRINGEML pharmaceutical products. The contract has a ceiling value of $8,401.68 and a period of performance through March 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 3/28/24 |